Holen Sie sich die Stockscreener-App
1.92
0.52%
0.01
Handel nachbörslich:
1.92
Schlusskurs vom Vortag:
$1.91
Offen:
$1.91
24-Stunden-Volumen:
107.64K
Relative Volume:
0.46
Marktkapitalisierung:
$85.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.54M
KGV:
-3.00
EPS:
-0.64
Netto-Cashflow:
$-22.72M
1W Leistung:
+2.67%
1M Leistung:
+12.28%
6M Leistung:
+10.34%
1J Leistung:
-56.85%
1-Tages-Spanne:
$1.91
$1.92
1-Wochen-Bereich:
$1.90
$1.93
52-Wochen-Spanne:
$1.40
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
Firmenname
Essa Pharma Inc
Sektor
Branche
Telefon
(778) 331-0962
Adresse
SUITE 720, VANCOUVER, BC
Vergleichen Sie EPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.92 | 84.69M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-04 | Herabstufung | Jefferies | Buy → Hold |
| 2024-11-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-11-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-03-04 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-11-02 | Eingeleitet | Jefferies | Buy |
| 2019-10-25 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Essa Pharma Inc Aktie (EPIX) Neueste Nachrichten
Visualizing ESSA Pharma Inc. stock with heatmaps2025 AllTime Highs & Safe Entry Point Alerts - Newser
Quantitative breakdown of ESSA Pharma Inc. recent moveJuly 2025 PreEarnings & Low Risk High Reward Ideas - Newser
ESSA Pharma: Fiscal Q3 Earnings Snapshot - San Antonio Express-News
ESSA Pharma Inc. SEC 10-Q Report - TradingView
Technical analysis overview for ESSA Pharma Inc. stockEarnings Growth Summary & AI Driven Stock Movement Reports - Newser
What the charts say about ESSA Pharma Inc. todayEarnings Overview Report & Fast Momentum Stock Entry Tips - Newser
Chart based analysis of ESSA Pharma Inc. trends2025 Momentum Check & Weekly Return Optimization Alerts - Newser
How to use Fibonacci retracement on ESSA Pharma Inc. [Portfolio Update Report]Verified Chart Pattern Signals - Newser
Can ESSA Pharma Inc. hit a new high this monthBreakout Watcher with Entry and Exit Alerts - Newser
ESSA Pharma Inc. stock chart pattern explainedLow Volatility Stock Analysis With Confidence - Newser
What machine learning models say about ESSA Pharma Inc. [2025 Market Overview]Stock Timing and Entry Methods - Newser
Is ESSA Pharma Inc. stock a good hedge against inflationStock Portfolio Risk and Return Analysis - Newser
Is ESSA Pharma Inc. reversing from oversold territoryFree Capital Preserving Trade Plan Templates - Newser
Published on: 2025-08-12 01:13:13 - Newser
Is ESSA Pharma Inc. meeting your algorithmic filter criteriaFree Community Strategy With High Win Rate - Newser
Evaluating ESSA Pharma Inc. with trendline analysisFree Weekly Chart Analysis With Entry Advice - Newser
How to use Fibonacci retracement on ESSA Pharma Inc.Smart Safety Strategy With Real Data Analysis - Newser
Using data tools to time your ESSA Pharma Inc. exitEquity Forecast with Predictive AI Screener - Newser
Detecting price anomalies in ESSA Pharma Inc. with AIPredictable Return Strategy with AI Support - Newser
How ESSA Pharma Inc. stock performs during market volatilityWeekly Setup Summary for Risk Controlled Trades - Newser
ESSA Pharma EPIX Q3 2025 Earnings Preview Upside Ahead on Strategic Partnerships and Innovations - AInvest
Will ESSA Pharma Inc. benefit from macro trendsWeekly Market Direction and Sector Summary - Newser
Will a bounce in ESSA Pharma Inc. offer an exitDaily Stock Forecast Powered by AI Tools - Newser
Top chart patterns to watch in ESSA Pharma Inc.3-Year Equity Summary With Setup Insights - Newser
Essa Pharma Inc. Announces US$80 Million Cash Distribution to Shareholders - 富途牛牛
ESSA Pharma Announces $80 Million Shareholder Distribution Amid Acquisition - The Globe and Mail
What makes ESSA Pharma Inc. stock price move sharplySector-Wise Equity Performance Trend Forecast - Newser
Essa Pharma announces $80M cash distribution to shareholders - TipRanks
Using R and stats models for ESSA Pharma Inc. forecastingFree Real Time Alerts Based on AI Prediction - Newser
ESSA Pharma to distribute $80 million to shareholders ahead of merger By Investing.com - Investing.com Nigeria
ESSA Pharma to distribute $80 million to shareholders ahead of merger - Investing.com
Why ESSA Pharma Inc. stock attracts strong analyst attentionStock Performance Summary Over One Year - Newser
Quant Models Detect Momentum Reversal in ESSA Pharma Inc.Trend Reversal Signal Prediction Strategy - beatles.ru
Why is ESSA Pharma Inc. stock attracting strong analyst attentionExceptional portfolio growth - Jammu Links News
Reversal Traders Monitor ESSA Pharma Inc. for EntrySwing Setup With Technical Confirmation Explained - metal.it
Does ESSA Pharma Inc. stock perform well during market downturnsFree Stock Movement Tracking - Jammu Links News
Is it the right time to buy ESSA Pharma Inc. stockCapitalize on fast-growing stocks today - Jammu Links News
Should I hold or sell ESSA Pharma Inc. stock in 2025Achieve rapid portfolio growth with smart picks - Jammu Links News
Is ESSA Pharma Inc. a growth stock or a value stockBreakout profit opportunities - Jammu Links News
How many analysts rate ESSA Pharma Inc. as a “Buy”Maximize portfolio returns with smart trading - Jammu Links News
What are the technical indicators suggesting about ESSA Pharma Inc.Outstanding capital growth - Jammu Links News
Finanzdaten der Essa Pharma Inc-Aktie (EPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):